Figure 3From: Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial Multivariate Cox regression analysis for DFS (A) and OS (B) presented by forest plots. Back to article page